• Latest Posts

Mage Biologics created to develop oral antibody therapy for ulcerative colitis

Lilly boosts obesity portfolio with Versanis Bio acquisition


UCB myasthenia gravis drug given FDA approval 

Sanofi drug reduces disease activity in relapsing MS

TORL BioTherapeutics launches with $158M to target cancer

Calida Therapeutics launches to tackle thrombo-inflammatory disorders

Purple Biotech sees positive results from cancer study

Disc Medicine raises $62.5M for hematology programs